glp-1 agonist therapy Non-insulin injectable antidiabetic drugs - agonists and amylinomimetics GLP-1 Therapy for Obesity Requires

Proc Natl Acad Sci USA 76:56065610 Inoue M (2016) Glutathionists in the battlefield of gamma-glutamyl cycle

A study of Australian sales data published in November found that since May 2020, total sales of these drugs in Australia increased almost 10-fold, reaching about half a million units each month in 2024/25, despite significant disruptions to access during shortages, with around 200,000 people now using them

Enhancing Insulin Secretion: They prompt the pancreas to release insulin when blood sugar rises, helping to manage glucose levels

And one shouldn't expect anything else from them

While other weight loss medications, like phentermine, have stimulating effects that help curb your appetite, Semaglutide works differently (see above)

Is GHK-Cu available as an injection or topical product